chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a 72 year old female patient and refers to herself. The patient was allergic to aspirin and penicillin. The patient did not have pertinent medical history. The patient described herself as very healthy person. On an unspecified date in approximately 2012 (reported as four years ago), the patient was vaccinated with a dose of ZOSTAVAX vial 19400 PFU (dose, route of administration, lot # and expiration date were not provided). Concomitant therapies included unspecified vitamins. On 22-JAN-2016, the patient went to an unspecified emergency room because of a "little rash" on her belly. She was diagnosed with shingles and treated with an unspecified medication. She "had it so bad for three weeks" that she "could not even describe the pain". She further stated that she "would rather have a child than this pain" (referring to shingles pain). The patient also reported experiencing headaches (onset date was not reported). Since 22-JAN-2016, the patient had had an additional emergency room visit in an unspecified facility, three primary care physician visits and one visit to an unspecified dermatologist. In addition to the unspecified medication prescribed at the first emergency room visit, she had been prescribed unspecified doses of LYRICA, a lidocaine (manufacturer unknown) patch and an unspecified prescription cream "like cortisone (manufacturer unknown)". The patient stated she was still in pain and that if she was not "doing better" in a week or so, her primary care physician would send her to a pain management physician. The patient did not have lab diagnostics studies performed. The patient sought medical attention. The outcome of the events was reported as not recovered/not resolved at the time of the report. The relatedness between the events and ZOSTAVAX was not reported. Additional information has been requested.
tested positive greater than 14 days post 2nd vaccine  Narrative: tested positive greater than 14 days post 2nd vaccine
Sweating, achiness throughout body, pain in left arm (where shot received); Pain in left armpit - approximately 3 days
Pt was admitted to the hospital on  4/24/2021, tested positive for COVID 19 on admission, non ICU
Chills, Body aches, Fever, Malaise, Congestion, Shortness of breath for 6 days
Myalgia, Fever, NauseaVomiting, chills Narrative:  Body aches, chills, nausea; in the evening developed temp of 102; states he is beginning to feel better - no body aches, reports he did test positive to COVID in September 2020.
4 episodes of: body stiffness, jerking movements, eyes roll back, lips & nose turn blue, lasted for 1-2min;occurred on 13MAY97, 28JUN97 3JUL97, 18JUL97 pt is sleepy p/episode currently pt is on tegretol;
I woke up at 0630 on 2 September with chills, sweating, severe headache, fatigue, nausea and explosive diarrhea. I spent the next 3 days suffering from the effects. It was not until Wed 6 September that I was able to function normally.
Patient inadvertently received vaccine after published expiration date. Moderna Company analyzed lot 007B21A and advised vaccine maintained activity needed to protect against covid 19 on date vaccine was administered.  Also patient did not call in to complain of adverse event.  This is administrative error without adverse event.
Mild looking Chicken Pox spots on rightleg /same side as immunization injection.  Also fever 102.6  This occured 1 week after the shot.
Pfizer 1/5/21, 10/22/21, 5/17/22. Positive on 2/6/23
5-20-13: pt received shingles vaccination on (L) deltoid. 6-12-13 pt return to clinic with 7 days Hx of (R) upper chest localized burning, tingling, itchy sensation, mild in nature, no rash.
6 hours after injection-severe headache (stabbing pain base of scull) and chills.  12 hours after injection-headache  persists with back/body aches.  24 hours after injection-symptoms gone
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered with expired vaccine) and NO ADVERSE EVENT (No adverse event) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination. No Medical History information was reported. In 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered with expired vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered with expired vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient was administered with expired vaccine). Concomitant product use was not provided by the reporter. The date of vaccine administration by patient was not known. It was unknown whether patient took first, second, first booster and or second booster dose. The date the vial was initially stored in the refrigerator was 07-Jun-2022. Number of doses/vials were 35 doses and 4 vials. The vial did not undergo any temperature excursions. The dates of administration of the vaccines were reported as 1-Apr-2022, 5-Apr-2022, 6-Apr-2022, 8-Apr-2022, 11-Apr-2022, 12-Apr-2022, 13-Apr-2022, 14-Apr-2022, 22-Apr-2022, 9-Jun-2022, 10-Jun-2022, 13-Jun-2022, 18-Jun-2022 and 22-Jun-2022. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2022-589423 (E2B Linked Report). Sender's Comments: US-MODERNATX, INC.-MOD-2022-589423: Master case.
Mild Tinnitus started after my first vaccine on 4/1/2021.  Tinnitus worsened after 2nd shot on 4/29/2021.  Tinnitus worsened after getting the booster on 12/17/2021.  One year later without getting any more boosters my Tinnitus has worsened with a new symptom of inner ear pain and heightened sensitivity to sound.  Pain is worse in my right ear but present in both.
Pt recvd series of 3 Engerix-B OCT90, NOV90, APR91 & APR91 titers were found to be neg; pt recvd 2 booster doses of Engerix-B MAY & JUN & SEP91 titers checked again & found to be neg; pt considered non-responder;
approximately 18 hours after receiving the injection experienced intense headache and chills, unpleasant but not sserious
I received my flu vaccine on 10/10/19. It was given to me by one of the medical assistants in the Employee Health Department. As the MA began to inject the vaccine, I felt an enormous amount of pain in the area where the needle had entered, and this was something I had never experienced prior when receiving any vaccine. After the injection was completed, I noted that the injection site seemed as if it was extremely high in my arm. I am a registered nurse, so I recognized right away that the injection was given very close to my shoulder joint. I immediately notified one of our NPs in the department who also said it looked like it was given too high. It is now almost one week later. My shoulder discomfort has continued. I have pain in the area of the right biceps, my arm feels heavy, and pain increases when I lift my arm. I am planning to see an orthopedic PA for evaluation if this problem persists.
On 10/23/2000 the patient was seen and diagnosed with early varicella. The patient developed 125 lesions, a low grade temperature and pruritus which was treated with Benadryl. On an unspecified date the patient recovered. No further information is available.
Sick for 30 hours; Sore arm; little bit of the needle was left out/didn't go all the way into the arm; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick for 30 hours), PAIN IN EXTREMITY (Sore arm) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (little bit of the needle was left out/didn't go all the way into the arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Sick for 30 hours), PAIN IN EXTREMITY (Sore arm) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (little bit of the needle was left out/didn't go all the way into the arm). At the time of the report, ILLNESS (Sick for 30 hours), PAIN IN EXTREMITY (Sore arm) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (little bit of the needle was left out/didn't go all the way into the arm) outcome was unknown.            No Concomitant product use was reported.  The patient went for a Moderna fourth shot and was concerned that vaccine technician didn't go all the way into the arm and said that a little bit of the needle was left out. The patient stated that they did not look at the administration of their vaccine. The patient reported that they had a sore arm after fourth dose and also stated that the patient was sick after the booster dose sick for 30 hours.  No treatment information was provided.   Reporter did not allow further contact
After giving vaccine patient started passing out and his body stared shaking as if he is having seizure. We started tapping his body and asked what he is feeling. He started responding 1-2 minutes. He said he is feeling weird and lightheaded, his body temp was high. But came down to normal in few minutes. Called 911. They took his vital signs and they were normal. Father took him to ER on EMT's advise.
.  Patient admitted 8 days after vaccination received IVIG and steroids.  Initial ECHO, EKG wnl.  Followed by rheumatology and cardiology.  Symptoms: persistent fever, diarrhea, abdominal pain, rash.
Pt reports joint pain (right wrist and right knee swelled up) and got rash ("little blisters") on palms of hands.
Feels like heart is occasionally fibrillating; High fever. 101 and above; Stomach problems; Of course painful arm. But that happened every time.; vaccine was cloudy pinkish in color; bnt162b2 on 19Oct2021 12:30 as third booster dose; bnt162b2 on 19Oct2021 12:30 as third booster dose; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection), via an unspecified route of administration, administered in Arm Right on 19Oct2021 12:30 (Lot Number: Ff2589) at the age of 65 years old, as third booster dose, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient is not pregnant. The patient previously received bnt162b2, administered in Arm Right on 06Mar2021 (Lot Number: EN6201) at the age of 64 years old, as first dose, single; and on 27Mar2021 14:00 (Lot Number: En6208) at the age of 64 years old, as second dose, single for covid-19 immunisation. The patient had no other vaccine in four weeks. The patient had no covid prior to vaccination and was not tested for covid post vaccination. The patient had no known allergies. It was reported that vaccine was cloudy pinkish in color on 19Oct2021 12:30. On 19Oct2021 16:00, the patient experienced high fever: 101 and above, stomach problems, feels like heart is occasionally fibrillating, of course painful arm but that happened every time. The patient did not receive any treatment for all the events. Outcome of the events feels like heart is occasionally fibrillating, high fever 101 and above, stomach problems and painful arm was not recovered.   Follow-up attempts are completed. No further information is expected.
Numbness from the arm to head and neuralgia occurred; Numbness from the arm to head and neuralgia occurred; Discomfort; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 38-year-old (non-pregnant) female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN0178) via an unspecified route of administration, administered in arm left on 24Apr2021 14:00 (at the age of 38-year-old) at dose 1, single for covid-19 immunisation. Medical history and concomitant medications were not reported. Patient did not have known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 24Apr2021 14:00 the patient experienced numbness from the arm to head and neuralgia occurred, discomfort. As soon as the vaccine was administered on the left arm, there was numbness from the arm to head, and neuralgia occurred. At the time of this reporting, there was neuralgia from head to end of foot only on the left side. It was not as much that normal life was impossible but there was discomfort. Patient did not receive treatment for the adverse events. Outcome of the events was resolving.    No follow-up attempts are needed. No further information is expected.
fine, sandpaper-like, morbiliform rash with pruritus to bilateral arms (circumferentially) including dorsal and palmar surfaces of hands and to posterior neck and bilateral upper shoulders and to bilateral hips and upper thighs, with erythema  - today is 7 days after injection and rash continues to extend distally and increase in density to areas. mild erythema and edema to injection site  fatigue No SOB or breathing difficulties.  No urticaria.
This spontaneous report was received from an unspecified reporter referring to a female patient of unknown age. The patient's medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with GARDASIL (concentration, route of administration, lot # and expiration date were not reported). The reporter stated that the patient was over the age of 26 years old when vaccinated, it was also reported no adverse events as a result of getting the vaccine out of the age range. Additional information has been requested.
dizzy, lightheaded, nauseated, hot flashes. checked patient's blood pressure which was normal gave her a water and an ice pack and asked her to sit longer until she felt better patient came up to counter, said she felt a lot better and left the store 30 min after administration
Very sore arm the morning after the shot, then developed a mild headache. Second day, headache is gone and arm is about 95% pain free.
a terrible diarrhea and it caused to flare in her digestive issues; a terrible diarrhea and it caused to flare in her digestive issues; Dyspepsia; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 10-Jun-2021 and was forwarded to Moderna on 10-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (a terrible diarrhea and it caused to flare in her digestive issues), CONDITION AGGRAVATED (a terrible diarrhea and it caused to flare in her digestive issues) and DYSPEPSIA (Dyspepsia) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Diverticulosis.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (a terrible diarrhea and it caused to flare in her digestive issues), CONDITION AGGRAVATED (a terrible diarrhea and it caused to flare in her digestive issues) and DYSPEPSIA (Dyspepsia). The patient was treated with LOPERAMIDE HYDROCHLORIDE for Diarrhoea, at a dose of 1 dosage form. At the time of the report, DIARRHOEA (a terrible diarrhea and it caused to flare in her digestive issues), CONDITION AGGRAVATED (a terrible diarrhea and it caused to flare in her digestive issues) and DYSPEPSIA (Dyspepsia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It was reported that the patient started taking teriflunomide Coated tablet 14 mg QD oral on 04-mar-2021.Around the same time of starting the Aubagio, the patient received her Moderna COVID vaccine, so the doctor was not sure which was causing the diarrhea but the Aubagio had been discontinued.
ACHES/PAINS; FEVER; NAUSEA; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 25-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 25-MAR-2021, the subject experienced aches/pains. On 25-MAR-2021, the subject experienced fever. On 25-MAR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from aches/pains, fever, and nausea on 26-MAR-2021. This report was non-serious.
Patient reported feelings of malaise, SOB, and non-specific symptoms on 4/22. Patient sought medical care for symptoms on 05/08/2021. Patient was noted to have multiple large ecchymosis scattered over upper and lower extremities bilaterally; Plt. count came back at 7k, and patient was diagnosed with ITP (no prior history of ITP).
23MAR mom called MD stated pt had screaming cry; pt cried to touch, lt leg appeared swollen, crying stopped early evening; 24FEB father stated pt fine; 25FEB MD office for umbilical check nothing mentioned about crying;
Before this vaccine, my thyroid antibody levels were in the 60s. Post-vaccine and into the next week I felt symptoms of my hashimotos thyroiditis flare (headache, exhaustion, swollen/pressure feeling in my throat). I got bloodwork done on 3/26 and my thyroid antibodies (TPO) were in the 270s (higher than I have ever seen). I got the TPO retested on 4/7 to see if they had come down any, and they were even higher, in the 350s. I still have increased symptoms of hashimotos thyroiditis including headache, exhaustion, and swollen/pressure feeling in my throat today 4/12.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 01-JUN-2011, the patient was inoculated with the ZOSTAVAX vaccine as recommended for routine adult health maintenance the intended purpose of the long-term prevention of shingles (dose, route, and lot number not provided). The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster or shingles. On or about 20-AUG-2016, the patient was treated for the onset of a vesicular rash, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX vaccine for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Whole-body muscle fatigue. Joint pain: toes, ankles, knees, shoulders, elbows, wrists, hands and fingers. Multiple blood tests with negative results. MRI spine and EMG arms and hands. Diagnosis: carpal tunnel both wrists. All previously listed joints remain inflamed and painful. Conditions did not exist before second COVID shot. Rheumatologist appointment scheduled for May 14. Hands are numb and affecting daily activities. Have seen primary doctor twice and neurologist twice.
red eyes w/pruritus; feverish feeling w/o documented fever; generalized weakness;
I felt like I had flu like symptoms and was very achy and sore all over. I had bronchitis at the time but have never had this before. I went to see my doctor due to the symptoms. I have since been diagnosed with pneumonia. Your prescribed antibiotics and recovered after 10 days.
Insomnia, followed by intense/throbbing arm pain and back/shoulder pain,  dry cough, and headaches
Fatigue decreased ROM redness edema, warm to touch firmness 1% Hydrocortisone.
Urticaria, wheezing, sore throat. Came to my office one hour after he left. Currently receiving a nebulizer treatment. Does not appear in respiratory distress.
tired; This case was reported by a consumer via call center representative and described the occurrence of tiredness in a 60-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date).   On 5th January 2021, the patient received the 2nd dose of Shingrix. On 5th January 2021, immediately after receiving Shingrix, the patient experienced tiredness. On an unknown date, the outcome of the tiredness was recovered/resolved.   It was unknown if the reporter considered the tiredness to be related to Shingrix.  Additional details were reported as follows: This case was reported by patient's mother. It was reported that the patient just got his booster (second) Shingrix dose and felt tired but was better at the time of reporting. The reporter did not consent to follow-up. This case was 1 of the 3 linked cases reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021001347:same reporter US-GLAXOSMITHKLINE-US2021001354:same reporter
gen hives-entire body 9AM-uncomfortable during the day;hives noticed @ 2PM by grandmother;
Patient is none speaknig.  Arrived to the clinic with an appointment to receive her 2nd dose of vaccine.  She received her 1st dose of Moderna on 3/10/2021 and missed her second dose appointment several times.  She arrived to our clinic and was asked which vaccine she received but due to language barrier, she was vaccinated with Pfizer 0.3 ml (the clinic was not given Moderna at the time).  Several signs were posted at the entrance to remind patients that the facility was administering Pfizer
Urticaria; This is a spontaneous report from a contactable nurse (patient). A 27-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot EK5730) intramuscular on 18Dec2020 at a single dose on the left arm as vaccine. Medical history was not reported. There were no concomitant medications (did not receive other vaccines within four weeks to the COVID vaccine and did not receive other medications within two weeks of vaccination). The patient had no known allergies to medications, food, or other products. The patient was vaccinated in a hospital (facility where the most recent COVID-19 vaccine was administered). The patient experienced urticaria on 18Dec2020 assessed as non-serious which did not result in death, not life threatening, did not caused/prolonged hospitalization, not disabling/incapacitating, did not cause congenital anomaly/birth defect. She was not pregnant at the time of vaccination. She was not diagnosed with COVID-19 prior to vaccination. She had Covid tested post vaccination (had been tested for COVID-19 since vaccination)- nasal swab result negative on 31Dec2020. Treatment for the event included Benadryl. The outcome of the event was recovered.  No follow-up attempts are possible. No further information is expected.